The Amazing Case Race Microlearning: Case Study 3 - Management of Care for Patients Diagnosed with Poorly Differentiated Carcinoma of the Lung
(1)
Microlearning | English | 2023 | 15 Min
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
This course provides a comprehensive overview of the multifaceted care required for patients diagnosed with poorly differentiated carcinoma of the lung. From diagnosis to treatment and ongoing care, participants will delve into the intricate aspects of managing this aggressive form of lung cancer.
Thoracic oncologists.
Upon completion of this activity, the participants should be able to: 
  • Implement an appropriate initial evaluation of a patient with suspicion concerning advanced lung cancer.
  • Recognize the diagnostic dilemma of poorly differentiated carcinoma of the lung.
  • Identify the role of expert consultation and the significance of choosing appropriate testing in diagnostic dilemmas.
  • Maria Baine, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
  • Misty Shields, MD, PhD, Indiana University Health, Indianapolis, INUSA
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you need any assistance with this activity, please email: education@iaslc.org.
Powered By